Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) reported Q3 EPS of ($0.08), $0.13 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $3.14 million versus the consensus estimate of $3.76 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals, Inc. (SNOA) click here.